Last updated: June 12, 2025
Sponsor: Icahn School of Medicine at Mount Sinai
Overall Status: Active - Recruiting
Phase
N/A
Condition
Bulimia
Binge Eating Disorder
Treatment
Circadian Reset Technology
VR Headset
Clinical Study ID
NCT06858774
STUDY-24-01454
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Ages 18+
Diagnosed with Binge Eating Disorder using EDA-5
English-speaking
Exclusion
Exclusion Criteria:
Pregnancy
Acute suicide risk/active suicidal ideation
PSQI score <5 indicating good sleep quality
A condition that may create a risk while using the VR headset including risk offalls, seizures, a heart condition, migraines, an eye or vision condition, or aninner ear condition.
Study Design
Total Participants: 40
Treatment Group(s): 2
Primary Treatment: Circadian Reset Technology
Phase:
Study Start date:
May 13, 2025
Estimated Completion Date:
November 30, 2026
Study Description
Connect with a study center
Department of Psychiatry, Eating and Weight Disorders Program
New York, New York 10028
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.